down arrow

NeoGenomics, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US64049M2098
USD
12.17
0.1 (0.83%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Azenta, Inc.
Lifestance Health Group, Inc.
Amedisys, Inc.
The Ensign Group, Inc.
Option Care Health, Inc.
RadNet, Inc.
Teladoc Health, Inc.
Acadia Healthcare Co., Inc.
Guardant Health, Inc.
NeoGenomics, Inc.
Ginkgo Bioworks Holdings, Inc.
Why is NeoGenomics, Inc. ?
1
Poor long term growth as Operating profit has grown by an annual rate -224.97% of over the last 5 years
2
Negative results in Jun 25
  • ROCE(HY) Lowest at -11.76%
  • DEBT-EQUITY RATIO (HY) Highest at 29.05 %
  • INVENTORY TURNOVER RATIO(HY) Lowest at 14.12 times
3
Risky - Negative Operating Profits
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -27.11%, its profits have risen by 16.7%
4
Underperformed the market in the last 1 year
  • Even though the market (S&P 500) has generated returns of 12.33% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -27.11% returns
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is NeoGenomics, Inc. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
NeoGenomics, Inc.
-31.71%
-0.09
80.58%
S&P 500
13.22%
0.61
20.17%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
11.24%
EBIT Growth (5y)
-224.97%
EBIT to Interest (avg)
-38.77
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.21
Sales to Capital Employed (avg)
0.43
Tax Ratio
1.35%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.07
EV to EBIT
-14.14
EV to EBITDA
-131.00
EV to Capital Employed
1.06
EV to Sales
1.70
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-7.51%
ROE (Latest)
-7.07%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD 14.05 MM

NET PROFIT(HY)

Higher at USD -48.29 MM

NET SALES(Q)

Highest at USD 181.33 MM

-11What is not working for the Company
ROCE(HY)

Lowest at -11.76%

DEBT-EQUITY RATIO (HY)

Highest at 29.05 %

INVENTORY TURNOVER RATIO(HY)

Lowest at 14.12 times

PRE-TAX PROFIT(Q)

Lowest at USD -26.07 MM

NET PROFIT(Q)

Lowest at USD -25.35 MM

EPS(Q)

Lowest at USD -0.35

Here's what is working for NeoGenomics, Inc.
Operating Cash Flow
Highest at USD 14.05 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Net Sales
Highest at USD 181.33 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Here's what is not working for NeoGenomics, Inc.
Pre-Tax Profit
At USD -26.07 MM has Fallen at -49.22%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit
At USD -25.35 MM has Fallen at -48.26%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (USD MM)

Pre-Tax Profit
Lowest at USD -26.07 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (USD MM)

Net Profit
Lowest at USD -25.35 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (USD MM)

EPS
Lowest at USD -0.35
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (USD)

Debt-Equity Ratio
Highest at 29.05 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Inventory Turnover Ratio
Lowest at 14.12 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."